The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Size Increase Is Anticipated For The Charcot-Marie-Tooth Disease Market Over The 2026–2030 Period?
The Charcot-Marie-Tooth disease market has experienced rapid expansion in recent years. Its projected growth will take it from $1.32 billion in 2025 to $1.6 billion in 2026, at a compound annual growth rate (CAGR) of 20.8%. The historical growth of this market stems from increased awareness of the genetic disorder, the expansion of neurology clinics, broader adoption of pain management, improved integration of physical therapy, and a concentrated focus on supportive care.
The charcot-marie-tooth disease market size is poised for significant expansion in the coming years. It is forecast to reach $3.37 billion by 2030, driven by a compound annual growth rate (CAGR) of 20.5%. This growth throughout the forecast period stems from gene therapy research, precision neurology, early genetic screening, rare disease funding, and patient advocacy initiatives. Prominent trends for the forecast period encompass an increasing focus on symptom management therapies, the broadening of genetic testing and diagnosis, enhanced utilization of supportive drug treatments, a surge in research for disease-modifying therapies, and the development of multidisciplinary care models.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24501&type=smp
Which Major Factors Are Driving The Expansion Of The Charcot-Marie-Tooth Disease Market?
The future growth of the charcot-marie-tooth disease market is anticipated to be driven by an escalation in healthcare expenditure. This spending encompasses all outlays on medical services, supplies, and activities dedicated to maintaining or improving health. Healthcare expenditure is on the rise due to the creation and adoption of advanced medical technologies, which necessitate significant costs for research, equipment, and specialized training, thereby inflating the total spending on healthcare services. This elevation in healthcare spending strengthens the demand for charcot-marie-tooth disease treatment by allowing for greater capital allocation into specialized therapies, diagnostic instruments, and supportive care, consequently broadening access to comprehensive disease management. For instance, in April 2025, the Office for National Statistics, a UK-based government agency, reported that healthcare spending increased by 6.5% between 2023 and 2024, representing a modest acceleration compared to the 6.3% rise observed in 2023. Hence, the substantial increase in healthcare expenditure will propel the expansion of the charcot-marie-tooth disease market.
How Is The Charcot-Marie-Tooth Disease Market Segmented Across Key Categories?
The charcot-marie-tooth disease market covered in this report is segmented –
1) By Disease Type: CMT 1, CMT 2, CMT 3, Other Disease Types
2) By Drug Type: Nonsteroidal Anti-Inflammatory Drugs, Cyclooxygenase-2 Inhibitors, Tricyclic Antidepressants, Anticonvulsants, Analgesics, Pipeline Drug
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Which Upcoming Trends Are Expected To Influence The Charcot-Marie-Tooth Disease Market?
Leading companies within the charcot-marie-tooth disease market are concentrating on developing advanced solutions, such as mesenchymal stem cell therapies, to simplify their isolation and expansion from various tissue sources. These therapies utilize versatile cells capable of differentiating into diverse tissue types, thereby assisting in healing and reducing inflammation across various health conditions. For instance, in March 2025, ENCell Co. Ltd., a biopharmaceutical company based in South Korea, announced that EN001, one of its mesenchymal stem cell therapies, had been granted orphan drug designation by the U.S. Food and Drug Administration. EN001 is specifically engineered to treat Charcot-Marie-Tooth (CMT) disease by enhancing cell survival and boosting the release of therapeutic molecules. Following its administration, the therapy aims to repair damaged nerves, encourage the secretion of healing factors, and support nerve remyelination. A phase 1 open-label, dose-escalation clinical study (NCT05333406) involving patients with type 1a CMT was conducted to assess the effectiveness of this therapy. Adopting a 3+3 trial design, the study evaluated its safety, tolerability, and optimal dosing over 16 weeks, with participants in the low-dose group receiving an intravenous dose on the first day.
Who Are The Dominant Players Shaping The Charcot-Marie-Tooth Disease Market Landscape?
Major companies operating in the charcot-marie-tooth disease market are Applied Therapeutics Inc., PTC Therapeutics Inc., Wave Life Sciences Ltd., Atalanta Therapeutics, Taysha Gene Therapies, Passage Bio Inc., Solid Biosciences Inc., Reata Pharmaceuticals, AskBio (Bayer subsidiary), Sarepta Gene Therapy, Forge Biologics, Neurogene Inc., Regenxbio Inc., Bluebird Bio Inc., GenSight Biologics SA, Rocket Pharmaceuticals Inc., Krystal Biotech Inc., Amicus Therapeutics Inc., Orchard Therapeutics plc, Anokion SA, Neurocrine Biosciences Inc., VectivBio Holding AG, Biomarin Pharmaceutical Inc., Travere Therapeutics Inc., Ascendis Pharma A/S
Read the full charcot-marie-tooth disease market report here:
https://www.thebusinessresearchcompany.com/report/charcot-marie-tooth-disease-global-market-report
Which Region Currently Holds The Largest Share Of The Charcot-Marie-Tooth Disease Market?
North America was the largest region in the charcot-marie-tooth disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the charcot-marie-tooth disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Charcot-Marie-Tooth Disease Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=24501&type=smp
Browse Through More Reports Similar to the Global Charcot-Marie-Tooth Disease Market 2026, By The Business Research Company
Pet Dental Health Market Report 2026
https://www.thebusinessresearchcompany.com/report/pet-dental-health-global-market-report
Dental Insurance Market Report 2026
https://www.thebusinessresearchcompany.com/report/dental-insurance-global-market-report
Invasive Fungal Infections Market Report 2026
https://www.thebusinessresearchcompany.com/report/invasive-fungal-infections-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model